700304 | Geranyl-L-Cysteine
(E)-3,7-Dimethylocta-2,6-dien-1-yl-L-cysteine
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Geranyl-L-Cysteine
(E)-3,7-Dimethylocta-2,6-dien-1-yl-L-cysteine
Geranyl-L-Cysteine is a natural compound that has gained significant attention in recent years due to its numerous health benefits. It is a derivative of geraniol (commonly found in plants and fruits such as roses, lemons, and oranges) and has been studied extensively for its antioxidant properties as well as its ability to support healthy immune function and reduce inflammation. All of these benefits shine the spotlight on this compound as an interesting possibility in the development of new drugs to treat inflammatory diseases such as arthritis and Crohn's disease.
In addition to its health benefits, Geranyl-L-Cysteine has a wide range of potential applications in the food, cosmetic, and pharmaceutical industries. It is commonly used as a flavoring agent in food products, and its antioxidant properties make it a popular ingredient in anti-aging creams and other skincare products.
How Geranyl-L-Cysteine Induces Insulin Release
Geranyl-L-Cysteine has been shown to have a significant impact on insulin sensitivity, making it a promising candidate for the treatment and management of conditions such as diabetes.
Research has demonstrated that Geranyl-L-Cysteine has the potential to enhance insulin sensitivity and improve glucose metabolism, which may help to prevent and manage diabetes. Studies have also shown that it can reduce oxidative stress and inflammation in the body, both of which are risk factors for diabetes and other chronic diseases.
Geranyl-L-Cysteine and Isoprenylated Protein Methyltransferase (ICMT)
Isoprenylated protein methyltransferase (ICMT) is an enzyme involved in the post-translational modification of proteins. Geranyl-L-Cysteine has been shown to have a direct inhibitory effect on ICMT activity, making it a promising candidate for the development of new drugs to treat diseases associated with aberrant ICMT activity.
Research has demonstrated that ICMT plays a critical role in the development and progression of various diseases, including cancer and cardiovascular disease. By inhibiting ICMT activity, Geranyl-L-Cysteine may help to prevent or slow the progression of these diseases by regulating protein function and signaling pathways.
The ability of Geranyl-L-Cysteine to modulate ICMT activity makes it a valuable tool for studying the role of ICMT in disease and developing new treatments for these conditions.
C13H23NO2S
C 60.66%, H 9.01%, N 5.44%, O 12.43%, S 12.46%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by Bioz
